Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.39
+0.03002.21%
Volume:202.77K
Turnover:284.35K
Market Cap:99.82M
PE:-0.60
High:1.44
Open:1.39
Low:1.36
Close:1.36
Loading ...
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Major Issues Report

Form 8-K - Current report
Jun 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 11, 2024

Major Issues Report

Form 8-K - Current report
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]